PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis. (April 2019) - Gkika, E.; Brunner, T.; Abbasi-Senger, N.; Alheit, H.; Baus, W.; Blanck, O.; Gerum, S.; Guckenberger, M.; Habermehl, D.; Ostheimer, C.; Riesterer, O.; Tamihardja, J.; et al.